SARS-CoV-2 induced Covid 19 and Influenza: The Dual overwhelming infection: Rising Attentions for Similarities
Main Article Content
Abstract
The multiple mutations of the Covid 19 virus worry people around the world, and the reason for this is very clear, as the last century witnessed four pandemics of influenza viruses, which are: H1N1 in 1918, H2N2 in 1957, H3N2 in 1968, and H1N1 in 2009 - which came in a second deadly wave In the fall and the beginning of winter. Covid-19 may behave in the same way, and the dangerous mutants of Covid have already seemed to sweep the world like the Indian strain. The worry that we might get a double overwhelming infection from the flu and the coronavirus is justified and could be very dangerous to humanity.
That the effect of this double overwhelming infection may be dangerous is more closely related to human behavior than to virology: as there are many similar characteristics common to the two viruses in virus transmission, spread, symptoms, and so on. Where both Covid-19 and influenza are transmitted - in most cases - through respiratory droplets, so the same prevention strategies used to limit the spread of the first will also work to limit the spread of the second and the speed of dealing with the first for sure from the second and so on. The aim of this descriptive minireview, generally, is to shed light on the SARS-CoV-2 induced Covid 19 and Influenza Dual overwhelming infection and the Rising attention to Similarities between them.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I H.UllahA.UllahA.GulT.MousaviM.W.Khan . Novel coronavirus 2019 (COVID-19) pandemic outbreak: A comprehensive review of the current literaturePandemia por el nuevo brote de coronavirus de 2019 (COVID-19): amplia revisión de la literatura actual. Vacunas 2021. Volume 22, Issue 2 : 106-113
II. F. Jiang, L. Deng, L. Zhang, Y. Cai, C.W. Cheung, Z. Xia . Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med, 4 (2020), pp. 1-5
III. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China. Lancet. 2020; 395(10223): 497– 506
IV. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020.
V. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75(7): 1730– 1741.
VI. Burden of influenza. CDC. Published April 17, 2020. Accessed July 13,
https://www.cdc.gov/flu/about/burden/index.html
VII. He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26(5):672-675.
VIII. Sakamoto H, Ishaan M, Ueda P. Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan. JAMA. 2020; 323(19):1969-1971.